Zhengye Biotechnology Holding Limited Accounts Payable

Zhengye Biotechnology Holding Limited (ZYBT) currently reports a accounts payable of $44M as of December 2025. That compares with $43M in the prior-year period — up 2.4% year over year. Use the charts on this page to explore Zhengye Biotechnology Holding Limited's accounts payable history and peer comparisons.

Zhengye Biotechnology Holding Limited's accounts payable increased from $43M to $44M — a 2.4% year-over-year increase (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Zhengye Biotechnology Holding Limited reported $44M in accounts payable as of December 2025. That compares with $43M in the prior-year period — up 2.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $44M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Zhengye Biotechnology Holding Limited, and consider following ZYBT for alerts when major investors trade the stock.